Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells

Cancer Letters

Volumn 236, Issue 2, 2006, Pages 222-228

  Chung, Byung Ha ^a   Lee, Hye young ^a   Lee, Jae Seok ^a   Young, Charles Y F ^b  

^a Kyung Hee University Hospital   (South Korea)

^b MAYO CLINIC   (United States)

Author keywords

Androgen receptor; Perillyl alcohol; Prostate carcinoma cell line LNCaP

Indexed keywords

ANDROGEN RECEPTOR; KALLIKREIN; LUCIFERASE; PERILLYL ALCOHOL; PROSTATE SPECIFIC ANTIGEN; PROTEIN C JUN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HORMONE INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TRANSCRIPTION TERMINATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, REPORTER; HUMANS; LUCIFERASES; MALE; MONOTERPENES; NANDROLONE; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, ANDROGEN; TISSUE KALLIKREINS; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

ANIMALIA;

EID: 33646509454     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.05.023     Document Type: Article

References (17)

1. Crowell P.L. Prevention and therapy of cancer by dietary monoterpenes. J. Nutr. 129 (1999) 775-778S
2. Horoszewicz J.S., Leong S.S., Kawinski E., Karr J.P., Rosenthal H., Chu T.M., et al. LNCaP model of human prostatic carcinoma. Cancer Res. 43 (1983) 1809-1818
3. Young C.Y., Andrews P.E., and Tindall D.J. Expression and androgenic regulation of human prostate-specific kallikreins. J. Androl. 16 (1995) 97-99
4. Zhang S., Hsieh M.L., Zhu W., Klee G.G., Tindall D.J., and Young C.Y. Interactive effects of triiodothyronine and androgens on prostate cell growth and gene expression. Endocrinology 140 (1999) 1665-1671
5. Hsieh M.L., Charlesworth M.C., Goodmanson M., Zhang S., Seay T., Klee G.G., et al. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D. Cancer Res. 57 (1997) 2651-2656
6. Klee G.G., Goodmanson M.K., Jacobsen S.J., Young C.Y., Finlay J.A., Rittenhouse H.G., et al. Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2. Clin. Chem. 45 (1999) 800-806
7. Ren F., Zhang S., Mitchell S.H., Butler R., and Young C.Y. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Oncogene 19 (2000) 1924-1932
8. Mitchell S.H., Murtha P.E., Zhang S., Zhu W., and Young C.Y. An androgen response element mediates LNCaP cell dependent androgen induction of the hK2 gene. Mol. Cell Endocrinol. 168 (2000) 89-99
9. Murtha P.E., Zhu W., Zhang J., Zhang S., and Young C.Y. Effects of Ca++ mobilization on expression of androgen-regulated genes: interference with androgen receptor-mediated transactivation by AP-I proteins. Prostate 33 (1997) 264-270
10. Tsai M.J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63 (1994) 451-486
11. Yang-Yen H.F., Chambard J.C., Sun Y.L., Smeal T., Schmidt T.J., Drouin J., and Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62 (1990) 1205-1215
12. Schule R., Rangarajan P., Kliewer S., Ransone L.J., Bolado J., Yang N., et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62 (1990) 1217-1226
13. Chung B.H., Mitchell S.H., Zhang J.S., and Young C.Y. Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells. Carcinogenesis 22 (2001) 1201-1206
14. Sato N., Sadar M.D., Bruchovsky N., Saatcioglu F., Rennie P.S., Sato S., et al. Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J. Biol. Chem. 272 (1997) 17485-17494
15. Wang Q., Lu J., and Yong E.L. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region. J. Biol. Chem. 276 (2001) 7493-7499
16. Fronsdal K., Engedal N., Slagsvold T., and Saatcioglu F. CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. J. Biol. Chem. 273 (1998) 31853-31859
17. Aarnisalo P., Palvimo J.J., and Janne O.A. CREB-binding protein in androgen receptor-mediated signaling. Proc. Natl Acad. Sci. USA 95 (1998) 2122-2127